Joseph E. Gilliam - Mar 14, 2024 Form 4 Insider Report for GLAUKOS Corp (GKOS)

Signature
Diana Scherer, Attorney-in-Fact
Stock symbol
GKOS
Transactions as of
Mar 14, 2024
Transactions value $
$0
Form type
4
Date filed
3/18/2024, 07:57 PM
Previous filing
Feb 12, 2024
Next filing
Apr 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GKOS Common Stock Award $0 +3.89K +3.95% $0.00 102K Mar 14, 2024 Direct F1, F2
transaction GKOS Common Stock Award $0 +8.74K +8.55% $0.00 111K Mar 14, 2024 Direct F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GKOS Stock Option (Right to Buy) Award $0 +3.66K +9.16% $0.00 43.6K Mar 14, 2024 Common Stock 3.66K $55.18 Direct F5, F6
transaction GKOS Stock Option (Right to Buy) Award $0 +15.2K $0.00 15.2K Mar 14, 2024 Common Stock 15.2K $85.78 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock underlying a portion of an award of restricted stock units previously granted by the Issuer on March 18, 2021, the earning and vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. The Compensation, Nominating & Governance Committee of the Issuer's Board of Directors (the "Compensation Committee") determined on March 14, 2024 that one of the operational targets had been achieved. The number of shares reported herein consists of the portion of the award that was deemed earned based upon the achievement of the operational target. 50% of the number of shares of common stock reported herein will vest and be delivered in March 2024 and the remaining 50% will vest and be delivered in December 2024.
F2 Includes 85,771 restricted stock units that have not yet vested or been delivered to the Reporting Person.
F3 Granted by the Issuer in the form of restricted stock units which vest over a four-year period, with 25% to vest on each anniversary of the grant date.
F4 Includes 94,514 restricted stock units that have not yet vested or delivery of which has been deferred by the Reporting Person.
F5 Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. The Compensation Committee determined on March 14, 2024 that certain of the operational targets had been achieved. The number of shares of common stock subject to the stock option as reported herein consists of the portion of the award that was earned based upon the achievement of the operational targets.
F6 50% of the portion of the option reported herein will vest and become exercisable in March 2024, and the remaining 50% will vest and become exercisable in December 2024.
F7 This option was granted on March 14, 2024 and has a four-year vesting schedule in which 25% vests on the first anniversary of the grant date and the remainder vests in equal monthly installments for 36 months thereafter, such that the stock option vests in full on the four-year anniversary of the grant date.